Colorectal cancer |
1.3809E-4 |
FOS, MSH2, APC |
Pathways in cancer |
0.0019 |
FOS, MSH2, APC, TCEB2 |
Metabolic pathways |
0.0021 |
ADH6, SAT1, EXT2, TGDS, BTD, PRPS1, AGPS |
Biotin metabolism |
0.0032 |
BTD |
MAPK signaling pathway |
0.0094 |
DUSP10, MAP2K4, FOS |
Cytokine-cytokine receptor interaction |
0.0098 |
CXCR4, ACVR2A, IL13RA1 |
Toll-like receptor signaling pathway |
0.0117 |
FOS, MAP2K4 |
Tight junction |
0.0196 |
PPP2R2 D, INADL |
Mismatch repair |
0.0361 |
MSH2 |
Glycosaminoglycan biosynthesis - heparan sulfate |
0.0408 |
EXT2 |
Pentose phosphate pathway |
0.0423 |
PRPS1 |
Endocytosis |
0.0428 |
ARAP1, CXCR4 |
|
PANTHER classification |
p-value |
Associated genes |
|
Oxidative stress response |
8.6417E-5 |
TXN, MAP2K4, DUSP10 |
O-antigen biosynthesis |
0.0064 |
TGDS |
T cell activation |
0.0083 |
FOS, B2M |
Interleukin signaling pathway |
0.0108 |
IL13RA1, FOS |
Apoptosis signaling pathway |
0.0133 |
ATF3, FOS |
FGF signaling pathway |
0.0135 |
MAP2K4, PPP2R2D |
Axon guidance mediated by Slit/Robo |
0.0253 |
CXCR4 |
Hypoxia response via HIF activation |
0.0408 |
TXN |
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade |
0.0484 |
FOS |